The only thing I hate is in his first line it says::
Summary
•Negative results from AMR-001 have already been priced into the stock.
Hello there where no negative results!
People see this and stand back without reading the rest!
As you say about the paragraph::
Atorvastatin, or Lipitor, the best-ever selling drug, which has over $115 billion in sales over about 15 years can improve LVEF by about 2.5% in 6 months and about 6% over 3 years. NBS10, however, when dosed at 20 million CD34+ or higher has been effective at improving a patient's LVEF about 10.2% in as little as 6 months, and one can only assume it could increase even further in the one-year results being presented March 15. This is a significant breakthrough for NeoStem, because this shows that the CD34+ cells are effectively healing the heart and improving the function of the heart.
The problem is the first line stopped a lot from reading further! Yes I think everybody should read it all BUT we all now that does not happen!!
News 
Market Data 
Discover 
